MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
A number of select phospho-peptides that are derived from the crystal-inhibiting protein osteopontin and that have a distinct set of structural criteria. More
These inventions describe novel ultrasound systems and methods of obtaining high quality three-dimensional (3-D) images of a target volume. More
It is patented combination of standardized extracts and is clinically proven (n= 126) to address all problems related to diabetes with Cardiovascular Complications. More
Exogenous Type IV Collagen and combinations promote recovery of cellular function following sublethal toxic injury and renal disease More
New methods for treating, minimizing and/or preventing inflammatory injury mediated by the activity of interleukin 2 (IL-2) on non-T cells, such as epithelial cells, expressing IL-2 receptors (IL-2R) More
Methods of administering N-acetylmannosamine or its derivative to treat muscular atrophy More
A micro-photonic pressure sensor based on PC waveguides is fabricated using planar SOI technology. More
This invention concerns the oral and intravenous administration of sodium 2-mercaptoethylsulfonate (MESNA) in the treatment of hyperhomocysteinemia. More
Name of the inventor: Jonathan M. Barasch A method of inducing the kidney epithelium formation is described. Methods of treating a subject with kidney failure, preserving a kidney for transplantation purposes are also proposed. The method involves... More
Displaying 1..10 of 10 - per page
Order by

Your selection

Therapeutic target
Genito-urinary del
Urinary del
Kidney disorder (other) del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us